Soleno Therapeutics Inc (SLNO) Options

The financial volume in the range of $200-500 per day does not tell me much. At the moment only small traders. Let's see if there will be an increase in interest in the coming days .
At the moment I am skeptical 😎

I had to stop reading after the first sentence,
When he used the word "raid" that said it all.

They are not raiding anything. They are auditing the department and we all know the SEC is so on the up and up.

Let's see what they find. USAID was an eye opener. I k

that thought did cross my mind but I'm supposed to be a libtard. My boobs aren't that much but I'll die laughing if he posts me back

I agree. I want the best price possible but if Naz can get an offer of 3 or more I would good with that but under 2 I would say wait but that's just mho.

Not necessarily. If R&D pipeline really is robust, we need time to execute. R&D pre-FDA filing isn't worth more than an FDA filing, which is less than an approved and launched product. R&D formulation lately has been slow to move due to all of the recent product launches, which is the reason to look

Yes? What "fraud" and "theft" have Musk and his proteges found? What they've bragged about finding?

Where's the proof? No one's seen any.

I'm expecting Fort Knox Audit to come up on a lot of missing gold -what happens to the price ? $$

https://www.mlb.com/news/giancarlo-stanton-dealing-with-sore-elbows-at-yankees-spring-training

Well i hope that you will be able to change that target from 2029 back to 2025. based on news from KT and lab.

Less R&D news , yes the world of science will love it and it could help the share value years from now , but i think investors that are in Lt care less by now of what happe

Yes, the approval for a share buyback can expire, depending on the jurisdiction and the specific terms set by the company or its governing body.

United States: In the U.S., share buyback programs authorized by a company's board of directors typically do not have a statutory expiration

Just remember the old saying a bird in the hand is better than 2 in the bush

https://www.mlb.com/news/starling-marte-ready-to-contribute-for-mets-in-2025

Likely the same result as Adderall IR & ER that were already crowded when Elite entered the market. We earned significant marketshare...

" style="caret-color: rgb(29, 38, 46); color: rgba(29, 38, 46, 1); font-family: DMSans-Regular, sans-serif; font-size: 15px".i think they were built in Lam Dong..."
style="caret-color: rgb(29, 38, 46); color: rgba(29, 38, 46, 1); font-family: DMSans-Regular, sans-serif; font-size: 15p

Yeah great ideal and what happens if 10 other generic drug makers get approved to manufacture Vyvanse over the next year?

Not sure...but these expenses are just being credited to the purchase price anyhow ;)

oh, coho is the tastiest fish I ever had. We cut the steaks up from the whale and they just don't shrink. It's seriously good fish. There's nothing else like it in my book, but I'm a bit of a homer. Waukegan harbor and I know each other very well.

Government E2E EBPP&H Common Sense!

USIO could help process, handle & verify government spending!

Follow digital money-trails, cut expenses...WIN-Win!

DEAL!

Interesting, Japan been accumulating XRP, now they want to offer ETF's, wonder if Japan will unload once it's approved, which it shouldn't be unless it's traded as a security! HMM

Robinhood didn't allow traders to buy at .50, now traders can trade it again at 2.50? HMM

Must be a sign of the bottom if ya ask me based on this posters history

Exciting

That would be generally helpful. Yes, his work on EVs has been interesting, but hardly problem-free. The same can be said of SpaceX.

The work can be carried on by people who are not drama queens.

I wouldn't be surprised if he was more attracted to yours.

Are you the regulatory expert on this board? Doubtful, like 99.99999% doubtful.

In my opinion, id only use trusted resources for information on the company and it's treatments.

Initiative gets noticed, whether required or not is irrelevant. ISO classification helps your company do more and earn more business. The entire process is more than worthwhile. It's a reassurance to your client base, regulators, prospective customers, investors, M&A candidates. Simply better busine